EP2341941A4 - Heparosan polymers and methods of making and using same for the enhancement of therapeutics - Google Patents

Heparosan polymers and methods of making and using same for the enhancement of therapeutics

Info

Publication number
EP2341941A4
EP2341941A4 EP09813350.7A EP09813350A EP2341941A4 EP 2341941 A4 EP2341941 A4 EP 2341941A4 EP 09813350 A EP09813350 A EP 09813350A EP 2341941 A4 EP2341941 A4 EP 2341941A4
Authority
EP
European Patent Office
Prior art keywords
therapeutics
enhancement
making
methods
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09813350.7A
Other languages
German (de)
French (fr)
Other versions
EP2341941A2 (en
Inventor
Paul L Deangelis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Oklahoma
Original Assignee
University of Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Oklahoma filed Critical University of Oklahoma
Publication of EP2341941A2 publication Critical patent/EP2341941A2/en
Publication of EP2341941A4 publication Critical patent/EP2341941A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
EP09813350.7A 2008-09-09 2009-09-09 Heparosan polymers and methods of making and using same for the enhancement of therapeutics Withdrawn EP2341941A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9557208P 2008-09-09 2008-09-09
US38304609A 2009-03-19 2009-03-19
US17927509P 2009-05-18 2009-05-18
PCT/US2009/005050 WO2010030342A2 (en) 2008-09-09 2009-09-09 Heparosan polymers and methods of making and using same for the enhancement of therapeutics

Publications (2)

Publication Number Publication Date
EP2341941A2 EP2341941A2 (en) 2011-07-13
EP2341941A4 true EP2341941A4 (en) 2014-12-10

Family

ID=44123336

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09813350.7A Withdrawn EP2341941A4 (en) 2008-09-09 2009-09-09 Heparosan polymers and methods of making and using same for the enhancement of therapeutics

Country Status (3)

Country Link
EP (1) EP2341941A4 (en)
CA (1) CA2773755C (en)
WO (1) WO2010030342A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580290B2 (en) 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
US9687559B2 (en) 2008-03-19 2017-06-27 The Board Of Regents Of The University Of Oklahoma Heparosan polymers and methods of making and using same for the enhancement of therapeutics
US9925209B2 (en) 2008-03-19 2018-03-27 The Board Of Regents Of The University Of Oklahoma Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
TR201802761T4 (en) 2012-03-30 2018-03-21 Univ Oklahoma High molecular weight heparosan polymers and methods for their production and use.
CN104903189B (en) 2012-09-17 2019-05-03 泰克尼普法国公司 Truss upright-column formula vortex-induced vibration damping with vertical plate
CN104661685A (en) * 2012-10-15 2015-05-27 诺和诺德保健Ag（股份有限公司） Factor vii conjugates
EP2906693A1 (en) * 2012-10-15 2015-08-19 Novo Nordisk Health Care AG Coagulation factor vii polypeptides
US9371370B2 (en) 2013-10-15 2016-06-21 Novo Nordisk Healthcare Ag Coagulation factor VII polypeptides
AR099340A1 (en) * 2014-02-12 2016-07-13 Novo Nordisk As CONJUGATES OF THE COAGULATION FACTOR IX
AR101060A1 (en) * 2014-02-12 2016-11-23 Novo Nordisk As FVIII CONJUGATES

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022331A1 (en) * 1991-06-06 1992-12-23 The School Of Pharmacy Pharmaceutical compositions
WO1997041897A1 (en) * 1996-05-09 1997-11-13 Virion Systems, Inc. Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
US20020192205A1 (en) * 2001-05-11 2002-12-19 Francis Michon Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US20040087488A1 (en) * 2002-07-02 2004-05-06 Genzyme Corporation Hydrophilic biopolymer-drug conjugates, their preparation and use
US20040197868A1 (en) * 2001-05-08 2004-10-07 Deangelis Paul L. Heparin/heparosan synthase from P. multocida, soluble and single action catalysts thereof and methods of making and using same
US20060105431A1 (en) * 1998-11-11 2006-05-18 Deangelis Paul L Polymer grafting by polysaccharide synthases using artificial sugar acceptors
US20060116346A1 (en) * 2002-10-18 2006-06-01 Fidia Farmaceutici S.P.A. Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
EP1870421A1 (en) * 2005-03-31 2007-12-26 Seikagaku Corporation Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
US20080109236A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
US20080112951A1 (en) * 2003-07-04 2008-05-15 Armelle Phalipon Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri
EP1923402A1 (en) * 2005-06-28 2008-05-21 Seikagaku Corporation Method for determination of enzymatic activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US7291673B2 (en) * 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6833488B2 (en) * 2001-03-30 2004-12-21 Exotech Bio Solution Ltd. Biocompatible, biodegradable, water-absorbent material and methods for its preparation
US8580290B2 (en) * 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
US6623729B2 (en) * 2001-07-09 2003-09-23 Korea Advanced Institute Of Science And Technology Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer
US7655445B2 (en) * 2003-11-12 2010-02-02 Massachusetts Institute Of Technology Methods for synthesis of sulfated saccharides

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022331A1 (en) * 1991-06-06 1992-12-23 The School Of Pharmacy Pharmaceutical compositions
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
WO1997041897A1 (en) * 1996-05-09 1997-11-13 Virion Systems, Inc. Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
US20080109236A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
US20060105431A1 (en) * 1998-11-11 2006-05-18 Deangelis Paul L Polymer grafting by polysaccharide synthases using artificial sugar acceptors
US20040197868A1 (en) * 2001-05-08 2004-10-07 Deangelis Paul L. Heparin/heparosan synthase from P. multocida, soluble and single action catalysts thereof and methods of making and using same
US20020192205A1 (en) * 2001-05-11 2002-12-19 Francis Michon Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
US20040087488A1 (en) * 2002-07-02 2004-05-06 Genzyme Corporation Hydrophilic biopolymer-drug conjugates, their preparation and use
US20060116346A1 (en) * 2002-10-18 2006-06-01 Fidia Farmaceutici S.P.A. Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
US20080112951A1 (en) * 2003-07-04 2008-05-15 Armelle Phalipon Glycoconjugates and Their Use as Potential Vaccines Against Infection by Shigella Flexneri
EP1870421A1 (en) * 2005-03-31 2007-12-26 Seikagaku Corporation Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
EP1923402A1 (en) * 2005-06-28 2008-05-21 Seikagaku Corporation Method for determination of enzymatic activity

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. E. SISMEY-RAGATZ ET AL: "Chemoenzymatic Synthesis with Distinct Pasteurella Heparosan Synthases: MONODISPERSE POLYMERS AND UNNATURAL STRUCTURES", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 39, 11 July 2007 (2007-07-11), pages 28321 - 28327, XP055116675, ISSN: 0021-9258, DOI: 10.1074/jbc.M701599200 *
KIYOSHI SUZUKI ET AL: "Generation and characterization of a series of monoclonal antibodies that specifically recognize [HexA(Ã Â+-2S)-GlcNAc]n epitopes in heparan sulfate", GLYCOCONJUGATE JOURNAL, KLUWER ACADEMIC PUBLISHERS, BO, vol. 25, no. 8, 7 May 2008 (2008-05-07), pages 703 - 712, XP019642419, ISSN: 1573-4986, DOI: 10.1007/S10719-008-9130-Z *

Also Published As

Publication number Publication date
WO2010030342A2 (en) 2010-03-18
CA2773755A1 (en) 2010-03-18
CA2773755C (en) 2017-04-25
WO2010030342A3 (en) 2010-06-17
EP2341941A2 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
IL267138A (en) Improved cell composition and methods of making the same
EP2341941A4 (en) Heparosan polymers and methods of making and using same for the enhancement of therapeutics
EG27167A (en) Microemulsifiers and methods of making and using same
AU2009234373A8 (en) Coferons and methods of making and using them
PL2290051T3 (en) Microorganism producing O-acetyl-homoserine and the method of producing O-acetyl-homoserine using the microorganism
EP2296879A4 (en) Polymeric blends and methods of using same
IL208205A0 (en) Bcr-complex-specific antibodies and methods of using same
PT3660073T (en) Low-burst polymers and methods to produce polymers
IL218310A (en) Actinic-ray or radiation-sensitive resin composition and method of forming pattern using the composition
EP2264079A4 (en) Copolymer and method for producing the same
HK1149933A1 (en) Diazacarbazoles and methods of use
PL3269819T3 (en) Microorganism producing o-acetyl-homoserine and the method of producing o-acetyl-homoserine using the microorganism
EP2207823A4 (en) Copolymer composition and method of producing the composition
EP2288365A4 (en) Targeted coagulation factors and method of using the same
EP2309938A4 (en) Cryo-surgical systems and methods of using the same
IL209548A0 (en) Diazacarbazoles and methods of use
EP2242854A4 (en) Sirna compounds and methods of use thereof
EP2282648A4 (en) Prebiotic composition and methods of making and using the same
EP2414321A4 (en) Hydrophobic monomers, hydrophobically-derivatized supports, and methods of making and using the same
EP2176066A4 (en) Structural member and method of producing the structural member
IL197655A0 (en) Emulsions and methods of their production
IL212388A0 (en) Solubilizer for metal ions and methods of producing the same
EP2267075A4 (en) Polyacetal resin composition and method for producing the same
EP2318508A4 (en) Determination of the integrity of rna
GB0800324D0 (en) Polymer and preparation process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110408

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20141110

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/10 20060101ALI20141104BHEP

Ipc: A61K 47/36 20060101ALI20141104BHEP

Ipc: A61K 47/48 20060101AFI20141104BHEP

Ipc: A61K 9/00 20060101ALI20141104BHEP

17Q First examination report despatched

Effective date: 20160901

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190221